Onconic Therapeutics Inc. (KOSDAQ:476060)

South Korea · Delayed Price · Currency is KRW

15,800

+950 (6.40%)

Aug 12, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Biotechnology	95.00M	60.00M
Total	95.00M	60.00M

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
South Korea	95.00M	60.00M
Total	95.00M	60.00M